Live feed
Filing
SC 13G
SC 13G0001193125-24-091977·AN2 Therapeutics, Inc.
Schedule 13G ownership disclosure
AN2 Therapeutics, Inc.
Security class unavailable
Event date: 2024-04-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-091977
- Form type
- SC 13G
- Filer
- AN2 Therapeutics, Inc.
- CIK
- CIK 1880438
- Filed
- Apr 10, 2024
- Reporting period
- Apr 03, 2024
- Description
- Schedule 13G beneficial ownership